![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 15/113 | (2010.01) |
A61K 31/713 | (2006.01) | ||
C07H 21/02 | (2006.01) |
(11) | Number of the document | 3204015 |
(13) | Kind of document | T |
(96) | European patent application number | 15848512.8 |
Date of filing the European patent application | 2015-10-09 | |
(97) | Date of publication of the European application | 2017-08-16 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
(46) | Date of publication of the claims translation | 2022-01-10 |
(86) | Number | PCT/US2015/054881 |
Date | 2015-10-09 |
(87) | Number | WO 2016/057893 |
Date | 2016-04-14 |
(30) | Number | Date | Country code |
201462062751 P | 2014-10-10 | US | |
201562147976 P | 2015-04-15 | US | |
201562214602 P | 2015-09-04 | US |
(72) |
QUERBES, William , US
FITZGERALD, Kevin , US
BETTENCOURT, Brian , US
LIEBOW, Abigail , US
ERBE, David V. , US
|
(73) |
Alnylam Pharmaceuticals, Inc. ,
675 West Kendall Street,
Henri. A. Termeer Square, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kompozicijos ir būdai, skirti HAO1 (hidroksirūgšties oksidazė 1 (glikolato oksidazė)) genų raiškos slopinimui |
COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION |
Payment date | Validity (years) | Amount | |
2024-09-18 | 10 | 231.00 EUR |
2025-10-09 |